The Development of Tinnitus in Patients With SSNHL: Insights From fMRI and Metabolomics
Launched by THE FIRST AFFILIATED HOSPITAL WITH NANJING MEDICAL UNIVERSITY · Apr 3, 2024
Trial Information
Current as of September 10, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The incidence rate of tinnitus is very high globally and shows an increasing trend year by year. Sudden sensorineural hearing loss (SSNHL) , a prevalent otolaryngological emergency, often coincides with tinnitus among its patient population. This condition can significantly impact individuals' interpersonal relationships, work performance, and daily functioning, ultimately leading to a diminished quality of life and even psychological disturbances, such as anxiety and depression. Consequently, it is imperative to expore the mechanisms underlying the emergence and chronicity of tinnitus foll...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- 1. Group of SSNHL with Tinnitus:
- • 1. Age between 18 and 65 years old;
- • 2. Meets the diagnostic criteria for SSNHL; untreated within 5 days after onset;
- • 3. Presence of tinnitus;
- • 4. Able to complete questionnaires independently and cooperate with fMRI and follow-up assessments.
- 2. Group of SSNHL without Tinnitus:
- • 1. Age between 18 and 65 years old;
- • 2. Meets the diagnostic criteria for SSNHL; untreated within 5 days after onset;
- • 3. Absence of tinnitus;
- • 4. Able to complete questionnaires independently and cooperate with fMRI and follow-up assessments.
- 3. Healthy Control:
- • 1. Age between 18 and 65 years old;
- • 2. Normal hearing screening results;
- • 3. Able to complete questionnaires independently and cooperate with fMRI and follow-up assessments.
- Exclusion Criteria:
- • 1. Previous diagnosis of otic organic diseases such as otitis media, cholesteatoma of the middle ear, Ménière's disease, acoustic neuroma, hereditary deafness, inner ear malformations, etc.; history of ear surgery; long-term exposure to noise; use of ototoxic drugs;
- • 2. Presence of brain organic diseases such as cerebral infarction, brain tumor, or contraindications for functional magnetic resonance imaging (fMRI) during nuclear magnetic resonance (NMR) examination;
- • 3. History of mental illness, including anxiety, depression, insomnia, etc.;
- • 4. Individuals unable to cooperate due to severe mental factors.
About The First Affiliated Hospital With Nanjing Medical University
The First Affiliated Hospital of Nanjing Medical University is a leading medical institution dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital is committed to implementing rigorous scientific methodologies to evaluate new therapies and treatment approaches. With a multidisciplinary team of experienced healthcare professionals and researchers, the hospital fosters a collaborative environment aimed at enhancing patient outcomes and contributing to the global medical community. Its strategic focus on translational medicine ensures that groundbreaking discoveries are efficiently translated into practical applications for patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nanjing, Jiangsu, China
Patients applied
Trial Officials
Liyuan Zhang, M.D.
Principal Investigator
Department of Otolaryngology, the First Affiliated Hospital, Nanjing Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported